Financial calendar 5 May 2004 Annual General Meeting Shareholder information Ownership structure Holdings by size as at 31 December 2003 Size of shareholding Number of % of Number of % of ordinary shares holdings total holdings ordinary shares Over 1,000,000 108 1.09 589,069,757 83.58 100,001 1,000,000 243 2.45 81,743,202 11.59 10,001 - 100,000 669 6.75 20,971,084 2.98 5,001 - 10,000 513 5.18 3,592,948 0.51 1,001 - 5,000 3,327 33.57 7,066,047 1.00 501 1,000 2,240 22.61 1,657,137 0.24 1 500 2,809 28.35 739,148 0.10 9,909 100.00 704,839,323 100.00 Directors Mr D H Brydon CBE Non-executive Chairman Mr J Fr Odfjell Non-executive Deputy Chairman Sir William Castell Chief Executive Mr G W Battersby Director of Human Resources Dr A Carr President, Amersham Biosciences Mr G F B Kerr Finance Director Mr P Loescher Chief Operating Officer Mr D Challen CBE Non-executive Director, appointed 5 August 2003 Mr J H Johansen Non-executive Director, employee representative Dr J S Patterson Non-executive Director Professor Sir Keith Peters Non-executive Director Mr J F Rejeange Non-executive Director Professor E Thorsby Non-executive Director Professor M Uhlen Non-executive Director Secretary and Registered Office Mr R E B Allnutt Amersham Place Little Chalfont Buckinghamshire HP7 9NA Telephone 44 0 1494 544000 Registered in England Wales No 1002610 76 CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 The Private Securities Litigation Reform Act of 1995 provides for a safe harbor for forward-looking statements.
This report contains words such as believe, expect and anticipate and similar expressions, that identify forward-looking statements, which reflect the groups views about future events and financial performance.
Such forward-looking statements relate to the outlook of Amersham plc, including in particular, the expected growth of certain of the groups products or the markets for those products and the impact of currency movements during 2004.
Actual results could differ materially from those projected in such forward looking statements as a result of various factors that may be beyond the control of the group.
The following important factors could cause actual results to differ materially from those projected or implied in any forward-looking statements: i Changes in demand for the products of Amersham plc worldwide or the markets for those products as well as changes in managements expectation of the development of new markets and the timing of completion of various trials leading to the introduction of new products: ii Changes in the cost or supply of raw materials, changes in interest rates and the impact of competition: and iii Price controls and price reductions, fluctuations in exchange rates for foreign currencies, changes in governmental regulation, and the risk of loss of patents or trademarks.
Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements.
In any event, these statements speak only as of the date on which they are made, and the group does not undertake any obligation to update or revise any of them, whether as a result of new information, future events or otherwise.
